Highly Sensitive Detection of Isoniazid Heteroresistance in Mycobacterium Tuberculosis by Droplet Digital PCR

References

• World Health Organization. Global tuberculosis control. WHO report 2011; 2021. Geneva, Switzerland: World Health Organization. Available from: https://apps.who.int/iris/rest/bitstreams/1379788/retrieve. Accessed June 7, 2022.
   Google Scholar
• Stagg HR, Lipman MC, McHugh TD, Jenkins HE. Isoniazid-resistant tuberculosis: a cause for concern? Int J Tuberc Lung Dis. 2017;21(2):129–139. doi:10.5588/ijtld.16.0716
   PubMed Web of Science ®Google Scholar
• O’Donnell M. Isoniazid Monoresistance: a Precursor to Multidrug-Resistant Tuberculosis? Ann Am Thorac Soc. 2018;15(3):306–307. doi:10.1513/AnnalsATS.201711-885ED
   Web of Science ®Google Scholar
• Manson AL, Cohen KA, Abeel T, et al. Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance. Nat Genet. 2017;49(3):395–402. doi:10.1038/ng.3767
   PubMed Web of Science ®Google Scholar
• Cohen KA, Abeel T, Manson McGuire A, et al. Evolution of extensively drug-resistant tuberculosis over four decades: whole genome sequencing and dating analysis of Mycobacterium tuberculosis isolates from KwaZulu-Natal. PLoS Med. 2015;12(9):e1001880. doi:10.1371/journal.pmed.1001880
   PubMed Web of Science ®Google Scholar
• The Editors null. Hetero-resistance: an under-recognised confounder in diagnosis and therapy? J Med Microbiol. 2001;50(12):1018–1020. doi:10.1099/0022-1317-50-12-1018
   Web of Science ®Google Scholar
• Andersson DI, Nicoloff H, Hjort K. Mechanisms and clinical relevance of bacterial heteroresistance. Nat Rev Microbiol. 2019;17(8):479–496. doi:10.1038/s41579-019-0218-1
   PubMed Web of Science ®Google Scholar
• Zetola NM, Shin SS, Tumedi KA, et al. Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes. J Clin Microbiol. 2014;52(7):2422–2429. doi:10.1128/JCM.02489-13
   PubMed Web of Science ®Google Scholar
• Ley SD, de Vos M, Van Rie A, Warren RM. Deciphering within-host microevolution of Mycobacterium tuberculosis through Whole-genome sequencing: the phenotypic impact and way forward. Microbiol Mol Biol Rev. 2019;83(2):e00062–e000618. doi:10.1128/MMBR.00062-18
   Web of Science ®Google Scholar
• Folkvardsen DB, Thomsen VØ, Rigouts L, et al. Rifampin heteroresistance in Mycobacterium tuberculosis cultures as detected by phenotypic and genotypic drug susceptibility test methods. J Clin Microbiol. 2013;51(12):4220–4222. doi:10.1128/JCM.01602-13
   Web of Science ®Google Scholar
• Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol. 2010;48(7):2495–2501. doi:10.1128/JCM.00128-10
   PubMed Web of Science ®Google Scholar
• Folkvardsen DB, Svensson E, Thomsen VØ, et al. Can molecular methods detect 1% isoniazid resistance in Mycobacterium tuberculosis? J Clin Microbiol. 2013;51(5):1596–1599. doi:10.1128/JCM.00472-13
   Web of Science ®Google Scholar
• Eilertson B, Maruri F, Blackman A, Herrera M, Samuels DC, Sterling TR. High proportion of heteroheteroin gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates. Antimicrob Agents Chemother. 2014;58(6):3270–3275. doi:10.1128/AAC.02066-13
   PubMed Web of Science ®Google Scholar
• Operario DJ, Koeppel AF, Turner SD, et al. Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis. PLoS One. 2017;12(5):e0176522. doi:10.1371/journal.pone.0176522
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhao B, Huang H, et al. Co-occurrence of amikacin-resistant and -susceptible Mycobacterium tuberculosis isolates in clinical samples from Beijing, China. J Antimicrob Chemother. 2013;68(7):1537–1542. doi:10.1093/jac/dkt082
   Web of Science ®Google Scholar
• Chakravorty S, Roh SS, Glass J, et al. Detection of isoniazid-, fluoroquinolone-, amikacin-, and kanamycin-resistant tuberculosis in an automated, multiplexed 10-color assay suitable for point-of-care use. J Clin Microbiol. 2017;55(1):183–198. doi:10.1128/JCM.01771-16
   Web of Science ®Google Scholar
• Fan Y, Chen J, Liu M, et al. Application of droplet digital PCR to detection of Mycobacterium tuberculosis and Mycobacterium leprae infections: a narrative review. Infect Drug Resist. 2022;15:1067–1076. doi:10.2147/IDR.S349607
   Web of Science ®Google Scholar
• Nyaruaba R, Mwaliko C, Kering KK, Wei H. Droplet digital PCR applications in the tuberculosis world. Tuberculosis. 2019;117:85–92. doi:10.1016/j.tube.2019.07.001
   PubMed Web of Science ®Google Scholar
• Daum LT, Konstantynovska OS, Solodiankin OS, et al. Next-generation sequencing for characterizing drug resistance-conferring Mycobacterium tuberculosis genes from clinical isolates in the Ukraine. J Clin Microbiol. 2018;56(6):e00009–e000018. doi:10.1128/JCM.00009-18
   Web of Science ®Google Scholar
• Liang B, Tan Y, Li Z, et al. Highly sensitive detection of isoniazid heteroresistance in Mycobacterium tuberculosis by deepmelt assay. J Clin Microbiol. 2018;56:2. doi:10.1128/JCM.01239-17
   Web of Science ®Google Scholar
• Yacoob FL, Philomina Jose B, Karunakaran Lelitha SD, Sreenivasan S. Primary multidrug resistant tuberculosis and utility of line probe assay for its detection in smear-positive sputum samples in a tertiary care hospital in South India. J Pathog. 2016;2016:6235618. doi:10.1155/2016/6235618
   Google Scholar
• Whale AS, Cowen S, Foy CA, Huggett JF. Methods for applying accurate digital PCR analysis on low copy DNA samples. PLoS One. 2013;8(3):e58177. doi:10.1371/journal.pone.0058177
   PubMed Web of Science ®Google Scholar
• Pholwat S, Stroup S, Foongladda S, Houpt E. Digital PCR to detect and quantify heteroresistance in drug resistant Mycobacterium tuberculosis. PLoS One. 2013;8(2):e57238. doi:10.1371/journal.pone.0057238
   PubMed Web of Science ®Google Scholar
• Hu S, Li G, Li H, et al. Rapid detection of isoniazid resistance in Mycobacterium tuberculosis isolates by use of real-time-PCR-based melting curve analysis. J Clin Microbiol. 2014;52(5):1644–1652. doi:10.1128/JCM.03395-13
   PubMed Web of Science ®Google Scholar
• Banu S, Pholwat S, Foongladda S, et al. Performance of TaqMan array card to detect TB drug resistance on direct specimens. PLoS One. 2017;12(5):e0177167. doi:10.1371/journal.pone.0177167
   Web of Science ®Google Scholar
• Jain A, Singh PK, Chooramani G, Dixit P, Malhotra HS. Drug resistance and associated genetic mutations among patients with suspected MDR-TB in Uttar Pradesh, India. Int J Tuberc Lung Dis. 2016;20(7):870–875. doi:10.5588/ijtld.15.0874
   PubMed Web of Science ®Google Scholar
• Nikam C, Patel R, Sadani M, et al. Redefining MTBDRplus test results: what do indeterminate results actually mean? Int J Tuberc Lung Dis. 2016;20(2):154–159. doi:10.5588/ijtld.15.0319
   Web of Science ®Google Scholar
• Hofmann-Thiel S, van Ingen J, Feldmann K, et al. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan. Eur Respir J. 2009;33(2):368–374. doi:10.1183/09031936.00089808
   PubMed Web of Science ®Google Scholar
• Tolani MP, D’souza DTB, Mistry NF. Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplus assay and their implication for treatment outcomes in patients from Mumbai, India. BMC Infect Dis. 2012;12:9. doi:10.1186/1471-2334-12-9
   PubMed Web of Science ®Google Scholar
• Shivekar SS, Kaliaperumal V, Brammacharry U, et al. Prevalence and factors associated with multidrug-resistant tuberculosis in South India. Sci Rep. 2020;10(1):17552. doi:10.1038/s41598-020-74432-y
   Web of Science ®Google Scholar
• Campbell PJ, Morlock GP, Sikes RD, et al. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2011;55(5):2032–2041. doi:10.1128/AAC.01550-10
   PubMed Web of Science ®Google Scholar
• Rodwell TC, Valafar F, Douglas J, et al. Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations. J Clin Microbiol. 2014;52(3):781–789. doi:10.1128/JCM.02701-13
   Web of Science ®Google Scholar